Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.

Journal of Nephrology
Andreana De MauriRoberta Rolla

Abstract

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a serine lipase that enhances the instability of the atherosclerotic plaques. While in the general and cardiac population Lp-PLA2 is recognized as an important determinant of cardiovascular (CV) accidents, no data are available for the renal population. The aim of this study was to evaluate the relationship between Lp-PLA2 and acute CV events in hemodialyzed patients. We enrolled 102 dialyzed patients, 63% male, age 71 years (59-78), 35% with diabetes, 54% hypertension, 40% coronary artery disease and 31% peripheral vascular disease. They were investigated for Lp-PLA2 (cut-off < 194 nmol/min/ml), lipoprotein profile and the occurrence of acute CV events and death in the subsequent 3 years of follow-up. The median (interquartile ranges) levels of Lp-PLA2, total-, HDL-, LDL-cholesterol and ApoB/ApoA lipoprotein ratio were 184.5 (156.5-214.5) nmol/min/ml, 158 (127-191) mg/dl, 41 (33-51) mg/dl, 79 (63-102) mg/dl and 0.72 (0.58-0.89), respectively. In 42% of patients, Lp-PLA2 was > 194 nmol/min/ml and total- and LDL-cholesterol were higher, as well as CV morbidity and mortality. During follow-up, 51% of patients developed at least one CV event; the median survival time was 36 mont...Continue Reading

References

Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew Zalewski, Colin Macphee
Jun 16, 2005·Kidney International·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
Aug 15, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Sawako KatoBengt Lindholm
Sep 4, 2008·Circulation·Patrick W SerruysUNKNOWN Integrated Biomarker and Imaging Study-2 Investigators
Jan 4, 2012·European Journal of Clinical Investigation·Karl WinklerUNKNOWN German Diabetes and Dialysis Study Investigators
Apr 1, 2014·The New England Journal of Medicine·Harvey D WhiteLars Wallentin
Sep 1, 2014·JAMA : the Journal of the American Medical Association·Michelle L O'DonoghueDylan L Steen
Oct 31, 2015·World Journal of Cardiology·Giuseppe MaiolinoGian Paolo Rossi

❮ Previous
Next ❯

Citations

Apr 19, 2019·The Journal of Dermatological Treatment·Paulina KilukIwona Flisiak
Dec 22, 2019·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Andreana De MauriRoberta Rolla
Sep 25, 2019·Journal of Clinical Medicine·Giulia SantagatiGiorgina Barbara Piccoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.